分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

P2Y6 receptor inhibition aggravates ischemic brain injury by reducing microglial phagocytosis

Ruo-Xue Wen, Hui Shen, Shu-Xian Huang, Li-Ping Wang, Zong-Wei Li, Peng Peng, Muyassar Mamtilahun, Yao-Hui Tang, Fan-Xia Shen, Heng-Li Tian, Guo-Yuan Yang, Zhi-Jun Zhang

Journal:CNS Neuroscience & Therapeutics

IF:4.07

DOI:10.1111/cns.13296

PMID:32154670

Published:2020-03-10

research field:肿瘤学分子生物学微生物组研究免疫学代谢性疾病

Abstract

Introduction Clearance of damaged cells and debris is beneficial for the functional recovery after ischemic brain injury. However, the specific phagocytic receptor that mediates microglial phagocytosis after ischemic stroke is unknown. Aim To investigate whether P2Y6 receptor-mediated microglial phagocytosis is beneficial for the debris clearance and functional recovery after ischemic stroke. Results The expression of the P2Y6 receptor in microglia increased within 3 days after transient middle cerebral artery occlusion. Inhibition of microglial phagocytosis by the selective inhibitor MRS2578 enlarged the brain atrophy and edema volume after ischemic stroke, subsequently aggravated neurological function as measured by modified neurological severity scores and Grid walking test. MRS2578 treatment had no effect on the expression of IL-1α, IL-1β, IL-6, IL-10, TNF-α, TGF-β, and MPO after ischemic stroke. Finally, we found that the expression of myosin light chain kinase decreased after microglial phagocytosis inhibition in the ischemic mouse brain, which suggested that myosin light chain kinase was involved in P2Y6 receptor-mediated phagocytosis. Conclusion Our results indicate that P2Y6 receptor-mediated microglial phagocytosis plays a beneficial role during the acute stage of ischemic stroke, which can be a therapeutic target for ischemic stroke.

本文使用的Yeasen产品

购物车
客服
转染试用